Canada Spends Logo

Explore our Budget 2026 analysis

Grant: DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)

University of Calgary

$120,000.00

Bridging Tested and Patient-Reported Cognition: Towards an Enlightened Interpretation of Cognitive Symptoms and the Broader Management of Cognitive Health in People with Multiple Sclerosis

FY 2025-26

Summary
Multiple sclerosis (MS), a disease of the brain and spinal cord, is a leading cause of neurological disability. Up to 70% of people with MS face cognitive difficulties. These challenges can disrupt employment, social roles, and quality of life. This research will test a non-invasive brain stimulation technique called anodal transcranial direct-current stimulation (atDCS), whereby a mild electrical current is delivered to a specific brain region. Early studies suggest that atDCS to parts of the prefrontal cortex improves thinking speed and executive functions. However, it is unknown whether repeating the procedure offers compounding/diminishing benefits, if atDCS benefits employment and patient-reported cognition, and if these changes in patient-reported cognition relate to employment and clinically tested cognition. This study will randomly assign people with MS to receive either active or sham (placebo) stimulation. All participants will receive active stimulation ~4 months later. Assessments occurring over ~9 months will capture changes in cognition on questionnaires and clinical tests, brain health on neuroimaging, and employment using questionnaires. By comparing these measures over time, both in response to and in the absence of active stimulation, we will learn whether repeated stimulation offers added/diminishing benefits and how self-reported experiences align with cognitive tests, imaged brain health, and employment. This research may improve personal health by identifying a safe treatment for MS cognitive symptoms. It may also guide clinicians and scientists in using patient-reported cognition to monitor MS progression and treatment response. At a population level, better management of cognition may help people with MS remain employed and socially engaged, reducing the burden of MS on families and the health care system. Ultimately, this work aims to improve quality of life for Canadians with MS and inform health services on how to better support them.
Program
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
556162
Name
Peters Aidan L
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Clinical
Prcname2
DT1 (Biomedical and/or Clinical Research) CGRS Doctoral
Projecttitle
Bridging Tested and Patient-Reported Cognition: Towards an Enlightened Interpretation of Cognitive Symptoms and the Broader Management of Cognitive Health in People with Multiple Sclerosis
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Keyworddelim
Cognition; Dorsolateral Prefrontal Cortex; Multiple Sclerosis; Neuroimaging; Neurology; Neuroplasticity; Neuropsychology; Non-Invasive Brain Stimulation; Patient-Reported Outcome Measures; Rehabilitation
Abstract
Multiple sclerosis (MS), a disease of the brain and spinal cord, is a leading cause of neurological disability. Up to 70% of people with MS face cognitive difficulties. These challenges can disrupt employment, social roles, and quality of life. This research will test a non-invasive brain stimulation technique called anodal transcranial direct-current stimulation (atDCS), whereby a mild electrical current is delivered to a specific brain region. Early studies suggest that atDCS to parts of the prefrontal cortex improves thinking speed and executive functions. However, it is unknown whether repeating the procedure offers compounding/diminishing benefits, if atDCS benefits employment and patient-reported cognition, and if these changes in patient-reported cognition relate to employment and clinically tested cognition. This study will randomly assign people with MS to receive either active or sham (placebo) stimulation. All participants will receive active stimulation ~4 months later. Assessments occurring over ~9 months will capture changes in cognition on questionnaires and clinical tests, brain health on neuroimaging, and employment using questionnaires. By comparing these measures over time, both in response to and in the absence of active stimulation, we will learn whether repeated stimulation offers added/diminishing benefits and how self-reported experiences align with cognitive tests, imaged brain health, and employment. This research may improve personal health by identifying a safe treatment for MS cognitive symptoms. It may also guide clinicians and scientists in using patient-reported cognition to monitor MS progression and treatment response. At a population level, better management of cognition may help people with MS remain employed and socially engaged, reducing the burden of MS on families and the health care system. Ultimately, this work aims to improve quality of life for Canadians with MS and inform health services on how to better support them.
Competitiondate
202511
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Peters, Aidan L
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~